TScan Therapeutics, Inc. , a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer.
Tscan Therapeutics stock last closed at $7.32, up 0.41% from the previous day, and has increased 215.52% in one year. It has overperformed other stocks in the Biotechnology industry by 2.38 percentage points. Tscan Therapeutics stock is currently +351.85% from its 52-week low of $1.62, and -18.67% from its 52-week high of $9.00.
At the moment, there are 47.88M TCRX shares outstanding. The market value of TCRX is $350.50M. In the last 24 hours, 92,052 TCRX shares were traded.
How to Buy Tscan Therapeutics Stock
Wondering how to invest in Tscan Therapeutics stock? Here's how.
Figure out where to buy Tscan Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you decide where to buy Tscan Therapeutics stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit money your investment account: Select your payment method and add your info.
Research Tscan Therapeutics stock: The Tscan Therapeutics ticker symbol is TCRX. Is Tscan Therapeutics stock a good investment? Should you buy shares of TCRX? How do TCRX's underlying business fundamentals look? Do top analysts think Tscan Therapeutics is a good buy? Why has TCRX's stock price moved recently? (Hint: Our stock analysis website can help you understand if TCRX is a good stock to buy).
Place your TCRX purchase: Decide if you will purchase TCRX shares at the current market price or use a limit order to purchase TCRX stock at a particular price.
Get the latest scoop on your investment in TCRX: Create a watchlist to watch your position in Tscan Therapeutics shares.
Step 1: Figure out where to buy Tscan Therapeutics stock
You need a brokerage account to access the NASDAQ market and buy TCRX stock.
A brokerage account allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our research, eToro is the best stock brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world financial markets: From Technology to Healthcare, New York to Shanghai — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal info so you are able to buy TCRX today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Tscan Therapeutics stock
Once you have chosen the best place to buy Tscan Therapeutics stock, it's crucial to analyze their stock prior to investing, so you actually wrap your head around the risk and upside.
Overview of key TCRX info
TCRX Price
$7.32
1w %
7.33%
1y %
215.52%
5y %
N/A
P/E
-5.38x
P/B
2.32x
P/S
22.8x
PEG
N/A
Revenue
$21.05M
Earnings
-$89.22M
Fore. Rev. Growth
-4.23%
Fore. Earn. Growth
N/A
Market Cap
$350.50M
Next Earnings
May 7, 2024
Next Dividend
N/A
Tscan Therapeutics Due Diligence Checks
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
Last year, TCRX revenue was $21.05M. During the last three year, TCRX's revenue has increased by 264% per year. This was faster than the Biotechnology industry average of 28.56%.
No, Tscan Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about TCRX?
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your TCRX purchase
There are two main options:
Market order: A market order is an order to buy or sell a security at the best price on the market. Market orders are usually the easiest way to buy.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at an exact dollar amount limit, place a limit order.
Hit the Open Trade button and eToro will execute the order.
If you need additional assistance buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Tscan Therapeutics share?
As of Apr 26, 2024, it costs $7.32 to buy one share of Tscan Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.41 shares of TCRX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.